HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 769-780 of 1,811
Drug study icon
CompletedNCT00889915

Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)

Official study title

A Randomized Controlled Trial of Methylphenidate Transdermal System (Daytrana), Lisdexamfetamine Dimesylate (Vyvanse), OROS MPH (Concerta), and Mixed Amphetamine Salts Extended Release (Adderall XR) in Children and Adolescents With ADHD

This study has finished and is no longer accepting participants.

In Durham
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Duke University
Drug study icon
CompletedNCT00218322

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Official study title

Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)

This study has finished and is no longer accepting participants.

In Boston
ADHD, AddictionMedication studyAges 15–30
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00485797

Effects of Ritalin on Postural Stability of Hyper Active Children

Official study title

Effects of Methylphenidate on Postural Stability of Children Suffer From Attention Deficit Hyperactivity Disorder (ADHD) Under Single and Dual Task Conditions.

This study has finished and is no longer accepting participants.

In Beersheba
ADHDMedication studyAges 6–12
Countries
Israel
Sponsor
Soroka University Medical Center
Drug study icon
CompletedNCT00320528

Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Official study title

An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder With or Without Comorbid Conditions

This study has finished and is no longer accepting participants.

Multiple locations, including Acireale
ADHDMedication studyAges 6–15
Countries
Italy
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT01069523

Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

Electrophysiological Effects of Guanfacine Extended-Release (GXR) on Inhibitory Control in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In San Antonio
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.